In January 2006, Keith C. Valentine was appointed as president and chief operating officer of NuVasive, Inc. Since joining NuVasive in January 2001, he has overseen product development, marketing, operations, intellectual property, and regulatory and quality affairs in varied executive roles. Valentine held other leadership positions including vice president of marketing at ORATEC Interventions and Medtronic Sofamor Denek. At Medtronic Sofamor Denek he also served as group director of the BMP biologics program, the interbody sales development effort, and international sales and marketing. Valentine holds a bachelor’s degree in business administration in management and biomedical sciences from Western Michigan University.